Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence study

J F B Schwensen, V W Nielsen, C V Nissen, C Sand, R Gniadecki, S F Thomsen

Original languageEnglish
JournalJournal of the European Academy of Dermatology and Venereology : JEADV
Volume35
Issue number5
Pages (from-to)e341-e343
ISSN0926-9959
DOIs
Publication statusPublished - May 2021

Keywords

  • Antibodies, Monoclonal, Humanized
  • Biological Products
  • Humans
  • Psoriasis/drug therapy
  • Retrospective Studies

Cite this